Jason V Coloma insider trades: Maze Therapeutics (MAZE) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Jason reports to the SEC
Open-market buys and sales
15 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 2, 2026 | MAZE | ↓ Sell | 31,908 | $30.26 | $965K | Coloma Family Trust | Nov 4, 2026 (2d) |
| Nov 2, 2026 | MAZE | ↓ Sell | 2,593 | $30.23 | $78K | The Coloma 2021 Irrevocable Trust | Nov 4, 2026 (2d) |
| Oct 1, 2026 | MAZE | ↓ Sell | 31,908 | $27.02 | $862K | Coloma Family Trust | Oct 2, 2026 (1d) |
| Oct 1, 2026 | MAZE | ↓ Sell | 2,593 | $27.02 | $70K | The Coloma 2021 Irrevocable Trust | Oct 2, 2026 (1d) |
| Sep 3, 2026 | MAZE | ↓ Sell | 22,638 | $26.24 | $594K | Direct | Sep 4, 2026 (1d) |
| Aug 3, 2026 | MAZE | ↓ Sell | 31,908 | $26.73 | $853K | Coloma Family Trust | Aug 5, 2026 (2d) |
| Aug 3, 2026 | MAZE | ↓ Sell | 2,593 | $26.74 | $69K | The Coloma 2021 Irrevocable Trust | Aug 5, 2026 (2d) |
| Jul 1, 2026 | MAZE | ↓ Sell | 31,908 | $29.98 | $957K | Coloma Family Trust | Jul 2, 2026 (1d) |
| Jul 1, 2026 | MAZE | ↓ Sell | 2,593 | $29.98 | $78K | The Coloma 2021 Irrevocable Trust | Jul 2, 2026 (1d) |
| Jun 23, 2026 | MAZE | ↓ Sell | 25,818 | $26.05 | $672K | Coloma Family Trust | Jun 24, 2026 (1d) |
| Jun 22, 2026 | MAZE | ↓ Sell | 2,040 | $26.00 | $53K | The Coloma 2021 Irrevocable Trust | Jun 24, 2026 (2d) |
| Jun 1, 2026 | MAZE | ↓ Sell | 6,090 | $26.20 | $160K | Coloma Family Trust | Jun 3, 2026 (2d) |
| Jun 1, 2026 | MAZE | ↓ Sell | 553 | $26.24 | $15K | The Coloma 2021 Irrevocable Trust | Jun 3, 2026 (2d) |
| May 26, 2026 | MAZE | ↓ Sell | 30,086 | $26.01 | $783K | Coloma Family Trust | May 27, 2026 (1d) |
| May 22, 2026 | MAZE | ↓ Sell | 2,478 | $26.00 | $64K | The Coloma 2021 Irrevocable Trust | May 27, 2026 (5d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other MAZE insiders
Open-market trades in the last 12 months
About Jason V Coloma's insider trades
Jason V Coloma is Chief Executive Officer at Maze Therapeutics (MAZE). Since May 22, 2026, Jason has reported no open-market purchases and 15 sales worth $6.3M on SEC Form 4. In the last 12 months: 15 sales ($6.3M).
Their filings also include grants and awards (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MAZE insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.